Matrix Metalloproteinase Expression Increases After Cerebral Focal Ischemia in Rats
- 1 May 1998
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 29 (5), 1020-1030
- https://doi.org/10.1161/01.str.29.5.1020
Abstract
Background and Purpose—Matrix metalloproteinases (MMPs) are a family of proteolytic enzymes that degrade the extracellular matrix and are implicated in numerous pathological conditions including atherosclerosis, inflammation, and tumor growth and metastasis. In the brain, the endothelial cell wall, strengthened by tight junctions, defines the blood-brain barrier (BBB). The extracellular matrix molecules constitute the basement membrane underlying the vasculature and play a critical role in maintaining the integrity of the BBB. After focal stroke, there is a breakdown of the BBB with an associated increase in vascular permeability, inflammatory cell influx, and neuronal cell death. The present study was designed to investigate the effects of MMP expression after stroke. Methods—Focal stroke was produced by permanent middle cerebral artery occlusion (MCAO) in the rat, and MMP protein expression was measured by Western blot and zymogram analysis over a time course ranging from 6 hours to 30 days (n=32). Immunohistochemistry at 1 and 5 days (n=8 and 6, respectively) was also utilized to characterize the expression of several MMPs and related proteins after stroke, including their cellular source. To test the hypothesis that early increased MMP-9 expression is involved in ischemic brain injury, a neutralizing monoclonal antibody directed against MMP-9 was administered intravenously (n=7 per group) 1 hour before MCAO, and infarct size was measured 24 hours later. Results—MMP expression increased progressively over time after stroke. After 12 hours, significant (PPPPConclusions—These results demonstrate that early increased MMP-9 expression in endothelial cells and infiltrating neutrophils is a significant response to cerebral focal ischemia and that selective inhibition of MMP-9 activity can significantly reduce brain injury after stroke.Keywords
This publication has 27 references indexed in Scilit:
- Regulation of Matrix Metalloproteinase Expression in Astrocytes, Microglia and NeuronsNeuroimmunomodulation, 1996
- Emerging treatments for stroke in humansTrends in Pharmacological Sciences, 1996
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.JCI Insight, 1994
- Inhibition of Matrix Metalloproteinase 9 Activation by a Specific Monoclonal AntibodyHybridoma, 1993
- Genetic hypertension and increased susceptibility to cerebral ischemiaNeuroscience & Biobehavioral Reviews, 1992
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Development of the blood-brain barrierTrends in Neurosciences, 1990
- A Semiautomated Method for Measuring Brain Infarct VolumeJournal of Cerebral Blood Flow & Metabolism, 1990
- Metastatic potential correlates with enzymatic degradation of basement membrane collagenNature, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970